Global Pharmacovigilance (PV) Market Size, Status and Forecast 2020-2026

May 2020 | 130 pages | ID: GB7D4BC0596FEN
QYResearch

Abstracts

This report focuses on the global Pharmacovigilance (PV) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacovigilance (PV) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Accenture
• Clinquest Group B.V.
• Cognizant
• Laboratory Corporation of America Holdings
• IBM Corporation
• ArisGlobal
• ICON plc.
• Capgemini
• ITClinical
• iMEDGlobal
• Foresight Group International AG
• TAKE Solutions Ltd.
• PAREXEL International Corporation
• BioClinica
• Wipro Ltd.
• United BioSource Corporation

Market segment by Type, the product can be split into

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

Market segment by Application, split into

• Hospitals
• Research Organizations
• Industrial

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pharmacovigilance (PV) status, future forecast, growth opportunity, key market and key players.
• To present the Pharmacovigilance (PV) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pharmacovigilance (PV) are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmacovigilance (PV) Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pharmacovigilance (PV) Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Spontaneous Reporting
  1.4.3 Intensified ADR Reporting
  1.4.4 Targeted Spontaneous Reporting
  1.4.5 Cohort Event Monitoring
  1.4.6 EHR Mining
1.5 Market by Application
  1.5.1 Global Pharmacovigilance (PV) Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Research Organizations
  1.5.4 Industrial
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pharmacovigilance (PV) Market Perspective (2015-2026)
2.2 Pharmacovigilance (PV) Growth Trends by Regions
  2.2.1 Pharmacovigilance (PV) Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pharmacovigilance (PV) Historic Market Share by Regions (2015-2020)
  2.2.3 Pharmacovigilance (PV) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pharmacovigilance (PV) Market Growth Strategy
  2.3.6 Primary Interviews with Key Pharmacovigilance (PV) Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pharmacovigilance (PV) Players by Market Size
  3.1.1 Global Top Pharmacovigilance (PV) Players by Revenue (2015-2020)
  3.1.2 Global Pharmacovigilance (PV) Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pharmacovigilance (PV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmacovigilance (PV) Market Concentration Ratio
  3.2.1 Global Pharmacovigilance (PV) Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Revenue in 2019
3.3 Pharmacovigilance (PV) Key Players Head office and Area Served
3.4 Key Players Pharmacovigilance (PV) Product Solution and Service
3.5 Date of Enter into Pharmacovigilance (PV) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pharmacovigilance (PV) Historic Market Size by Type (2015-2020)
4.2 Global Pharmacovigilance (PV) Forecasted Market Size by Type (2021-2026)

5 PHARMACOVIGILANCE (PV) BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pharmacovigilance (PV) Market Size by Application (2015-2020)
5.2 Global Pharmacovigilance (PV) Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pharmacovigilance (PV) Market Size (2015-2020)
6.2 Pharmacovigilance (PV) Key Players in North America (2019-2020)
6.3 North America Pharmacovigilance (PV) Market Size by Type (2015-2020)
6.4 North America Pharmacovigilance (PV) Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pharmacovigilance (PV) Market Size (2015-2020)
7.2 Pharmacovigilance (PV) Key Players in Europe (2019-2020)
7.3 Europe Pharmacovigilance (PV) Market Size by Type (2015-2020)
7.4 Europe Pharmacovigilance (PV) Market Size by Application (2015-2020)

8 CHINA

8.1 China Pharmacovigilance (PV) Market Size (2015-2020)
8.2 Pharmacovigilance (PV) Key Players in China (2019-2020)
8.3 China Pharmacovigilance (PV) Market Size by Type (2015-2020)
8.4 China Pharmacovigilance (PV) Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pharmacovigilance (PV) Market Size (2015-2020)
9.2 Pharmacovigilance (PV) Key Players in Japan (2019-2020)
9.3 Japan Pharmacovigilance (PV) Market Size by Type (2015-2020)
9.4 Japan Pharmacovigilance (PV) Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pharmacovigilance (PV) Market Size (2015-2020)
10.2 Pharmacovigilance (PV) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmacovigilance (PV) Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmacovigilance (PV) Market Size by Application (2015-2020)

11 INDIA

11.1 India Pharmacovigilance (PV) Market Size (2015-2020)
11.2 Pharmacovigilance (PV) Key Players in India (2019-2020)
11.3 India Pharmacovigilance (PV) Market Size by Type (2015-2020)
11.4 India Pharmacovigilance (PV) Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pharmacovigilance (PV) Market Size (2015-2020)
12.2 Pharmacovigilance (PV) Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmacovigilance (PV) Market Size by Type (2015-2020)
12.4 Central & South America Pharmacovigilance (PV) Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Accenture
  13.1.1 Accenture Company Details
  13.1.2 Accenture Business Overview and Its Total Revenue
  13.1.3 Accenture Pharmacovigilance (PV) Introduction
  13.1.4 Accenture Revenue in Pharmacovigilance (PV) Business (2015-2020))
  13.1.5 Accenture Recent Development
13.2 Clinquest Group B.V.
  13.2.1 Clinquest Group B.V. Company Details
  13.2.2 Clinquest Group B.V. Business Overview and Its Total Revenue
  13.2.3 Clinquest Group B.V. Pharmacovigilance (PV) Introduction
  13.2.4 Clinquest Group B.V. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  13.2.5 Clinquest Group B.V. Recent Development
13.3 Cognizant
  13.3.1 Cognizant Company Details
  13.3.2 Cognizant Business Overview and Its Total Revenue
  13.3.3 Cognizant Pharmacovigilance (PV) Introduction
  13.3.4 Cognizant Revenue in Pharmacovigilance (PV) Business (2015-2020)
  13.3.5 Cognizant Recent Development
13.4 Laboratory Corporation of America Holdings
  13.4.1 Laboratory Corporation of America Holdings Company Details
  13.4.2 Laboratory Corporation of America Holdings Business Overview and Its Total Revenue
  13.4.3 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Introduction
  13.4.4 Laboratory Corporation of America Holdings Revenue in Pharmacovigilance (PV) Business (2015-2020)
  13.4.5 Laboratory Corporation of America Holdings Recent Development
13.5 IBM Corporation
  13.5.1 IBM Corporation Company Details
  13.5.2 IBM Corporation Business Overview and Its Total Revenue
  13.5.3 IBM Corporation Pharmacovigilance (PV) Introduction
  13.5.4 IBM Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020)
  13.5.5 IBM Corporation Recent Development
13.6 ArisGlobal
  13.6.1 ArisGlobal Company Details
  13.6.2 ArisGlobal Business Overview and Its Total Revenue
  13.6.3 ArisGlobal Pharmacovigilance (PV) Introduction
  13.6.4 ArisGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020)
  13.6.5 ArisGlobal Recent Development
13.7 ICON plc.
  13.7.1 ICON plc. Company Details
  13.7.2 ICON plc. Business Overview and Its Total Revenue
  13.7.3 ICON plc. Pharmacovigilance (PV) Introduction
  13.7.4 ICON plc. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  13.7.5 ICON plc. Recent Development
13.8 Capgemini
  13.8.1 Capgemini Company Details
  13.8.2 Capgemini Business Overview and Its Total Revenue
  13.8.3 Capgemini Pharmacovigilance (PV) Introduction
  13.8.4 Capgemini Revenue in Pharmacovigilance (PV) Business (2015-2020)
  13.8.5 Capgemini Recent Development
13.9 ITClinical
  13.9.1 ITClinical Company Details
  13.9.2 ITClinical Business Overview and Its Total Revenue
  13.9.3 ITClinical Pharmacovigilance (PV) Introduction
  13.9.4 ITClinical Revenue in Pharmacovigilance (PV) Business (2015-2020)
  13.9.5 ITClinical Recent Development
13.10 iMEDGlobal
  13.10.1 iMEDGlobal Company Details
  13.10.2 iMEDGlobal Business Overview and Its Total Revenue
  13.10.3 iMEDGlobal Pharmacovigilance (PV) Introduction
  13.10.4 iMEDGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020)
  13.10.5 iMEDGlobal Recent Development
13.11 Foresight Group International AG
  10.11.1 Foresight Group International AG Company Details
  10.11.2 Foresight Group International AG Business Overview and Its Total Revenue
  10.11.3 Foresight Group International AG Pharmacovigilance (PV) Introduction
  10.11.4 Foresight Group International AG Revenue in Pharmacovigilance (PV) Business (2015-2020)
  10.11.5 Foresight Group International AG Recent Development
13.12 TAKE Solutions Ltd.
  10.12.1 TAKE Solutions Ltd. Company Details
  10.12.2 TAKE Solutions Ltd. Business Overview and Its Total Revenue
  10.12.3 TAKE Solutions Ltd. Pharmacovigilance (PV) Introduction
  10.12.4 TAKE Solutions Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  10.12.5 TAKE Solutions Ltd. Recent Development
13.13 PAREXEL International Corporation
  10.13.1 PAREXEL International Corporation Company Details
  10.13.2 PAREXEL International Corporation Business Overview and Its Total Revenue
  10.13.3 PAREXEL International Corporation Pharmacovigilance (PV) Introduction
  10.13.4 PAREXEL International Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020)
  10.13.5 PAREXEL International Corporation Recent Development
13.14 BioClinica
  10.14.1 BioClinica Company Details
  10.14.2 BioClinica Business Overview and Its Total Revenue
  10.14.3 BioClinica Pharmacovigilance (PV) Introduction
  10.14.4 BioClinica Revenue in Pharmacovigilance (PV) Business (2015-2020)
  10.14.5 BioClinica Recent Development
13.15 Wipro Ltd.
  10.15.1 Wipro Ltd. Company Details
  10.15.2 Wipro Ltd. Business Overview and Its Total Revenue
  10.15.3 Wipro Ltd. Pharmacovigilance (PV) Introduction
  10.15.4 Wipro Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  10.15.5 Wipro Ltd. Recent Development
13.16 United BioSource Corporation
  10.16.1 United BioSource Corporation Company Details
  10.16.2 United BioSource Corporation Business Overview and Its Total Revenue
  10.16.3 United BioSource Corporation Pharmacovigilance (PV) Introduction
  10.16.4 United BioSource Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020)
  10.16.5 United BioSource Corporation Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pharmacovigilance (PV) Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmacovigilance (PV) Revenue
Table 3. Ranking of Global Top Pharmacovigilance (PV) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmacovigilance (PV) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Spontaneous Reporting
Table 6. Key Players of Intensified ADR Reporting
Table 7. Key Players of Targeted Spontaneous Reporting
Table 8. Key Players of Cohort Event Monitoring
Table 9. Key Players of EHR Mining
Table 10. Global Pharmacovigilance (PV) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Pharmacovigilance (PV) Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Pharmacovigilance (PV) Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Pharmacovigilance (PV) Market Share by Regions (2015-2020)
Table 14. Global Pharmacovigilance (PV) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Pharmacovigilance (PV) Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Pharmacovigilance (PV) Market Growth Strategy
Table 20. Main Points Interviewed from Key Pharmacovigilance (PV) Players
Table 21. Global Pharmacovigilance (PV) Revenue by Players (2015-2020) (Million US$)
Table 22. Global Pharmacovigilance (PV) Market Share by Players (2015-2020)
Table 23. Global Top Pharmacovigilance (PV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance (PV) as of 2019)
Table 24. Global Pharmacovigilance (PV) by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Pharmacovigilance (PV) Product Solution and Service
Table 27. Date of Enter into Pharmacovigilance (PV) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$)
Table 30. Global Pharmacovigilance (PV) Market Size Share by Type (2015-2020)
Table 31. Global Pharmacovigilance (PV) Revenue Market Share by Type (2021-2026)
Table 32. Global Pharmacovigilance (PV) Market Size Share by Application (2015-2020)
Table 33. Global Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$)
Table 34. Global Pharmacovigilance (PV) Market Size Share by Application (2021-2026)
Table 35. North America Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Pharmacovigilance (PV) Market Share (2019-2020)
Table 37. North America Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$)
Table 38. North America Pharmacovigilance (PV) Market Share by Type (2015-2020)
Table 39. North America Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$)
Table 40. North America Pharmacovigilance (PV) Market Share by Application (2015-2020)
Table 41. Europe Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Pharmacovigilance (PV) Market Share (2019-2020)
Table 43. Europe Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Pharmacovigilance (PV) Market Share by Type (2015-2020)
Table 45. Europe Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Pharmacovigilance (PV) Market Share by Application (2015-2020)
Table 47. China Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$)
Table 48. China Key Players Pharmacovigilance (PV) Market Share (2019-2020)
Table 49. China Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$)
Table 50. China Pharmacovigilance (PV) Market Share by Type (2015-2020)
Table 51. China Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$)
Table 52. China Pharmacovigilance (PV) Market Share by Application (2015-2020)
Table 53. Japan Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Pharmacovigilance (PV) Market Share (2019-2020)
Table 55. Japan Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Pharmacovigilance (PV) Market Share by Type (2015-2020)
Table 57. Japan Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Pharmacovigilance (PV) Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Pharmacovigilance (PV) Market Share (2019-2020)
Table 61. Southeast Asia Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Pharmacovigilance (PV) Market Share by Type (2015-2020)
Table 63. Southeast Asia Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Pharmacovigilance (PV) Market Share by Application (2015-2020)
Table 65. India Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$)
Table 66. India Key Players Pharmacovigilance (PV) Market Share (2019-2020)
Table 67. India Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$)
Table 68. India Pharmacovigilance (PV) Market Share by Type (2015-2020)
Table 69. India Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$)
Table 70. India Pharmacovigilance (PV) Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Pharmacovigilance (PV) Market Share (2019-2020)
Table 73. Central & South America Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Pharmacovigilance (PV) Market Share by Type (2015-2020)
Table 75. Central & South America Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Pharmacovigilance (PV) Market Share by Application (2015-2020)
Table 77. Accenture Company Details
Table 78. Accenture Business Overview
Table 79. Accenture Product
Table 80. Accenture Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 81. Accenture Recent Development
Table 82. Clinquest Group B.V. Company Details
Table 83. Clinquest Group B.V. Business Overview
Table 84. Clinquest Group B.V. Product
Table 85. Clinquest Group B.V. Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 86. Clinquest Group B.V. Recent Development
Table 87. Cognizant Company Details
Table 88. Cognizant Business Overview
Table 89. Cognizant Product
Table 90. Cognizant Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 91. Cognizant Recent Development
Table 92. Laboratory Corporation of America Holdings Company Details
Table 93. Laboratory Corporation of America Holdings Business Overview
Table 94. Laboratory Corporation of America Holdings Product
Table 95. Laboratory Corporation of America Holdings Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 96. Laboratory Corporation of America Holdings Recent Development
Table 97. IBM Corporation Company Details
Table 98. IBM Corporation Business Overview
Table 99. IBM Corporation Product
Table 100. IBM Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 101. IBM Corporation Recent Development
Table 102. ArisGlobal Company Details
Table 103. ArisGlobal Business Overview
Table 104. ArisGlobal Product
Table 105. ArisGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 106. ArisGlobal Recent Development
Table 107. ICON plc. Company Details
Table 108. ICON plc. Business Overview
Table 109. ICON plc. Product
Table 110. ICON plc. Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 111. ICON plc. Recent Development
Table 112. Capgemini Business Overview
Table 113. Capgemini Product
Table 114. Capgemini Company Details
Table 115. Capgemini Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 116. Capgemini Recent Development
Table 117. ITClinical Company Details
Table 118. ITClinical Business Overview
Table 119. ITClinical Product
Table 120. ITClinical Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 121. ITClinical Recent Development
Table 122. iMEDGlobal Company Details
Table 123. iMEDGlobal Business Overview
Table 124. iMEDGlobal Product
Table 125. iMEDGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 126. iMEDGlobal Recent Development
Table 127. Foresight Group International AG Company Details
Table 128. Foresight Group International AG Business Overview
Table 129. Foresight Group International AG Product
Table 130. Foresight Group International AG Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 131. Foresight Group International AG Recent Development
Table 132. TAKE Solutions Ltd. Company Details
Table 133. TAKE Solutions Ltd. Business Overview
Table 134. TAKE Solutions Ltd. Product
Table 135. TAKE Solutions Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 136. TAKE Solutions Ltd. Recent Development
Table 137. PAREXEL International Corporation Company Details
Table 138. PAREXEL International Corporation Business Overview
Table 139. PAREXEL International Corporation Product
Table 140. PAREXEL International Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 141. PAREXEL International Corporation Recent Development
Table 142. BioClinica Company Details
Table 143. BioClinica Business Overview
Table 144. BioClinica Product
Table 145. BioClinica Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 146. BioClinica Recent Development
Table 147. Wipro Ltd. Company Details
Table 148. Wipro Ltd. Business Overview
Table 149. Wipro Ltd. Product
Table 150. Wipro Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 151. Wipro Ltd. Recent Development
Table 152. United BioSource Corporation Company Details
Table 153. United BioSource Corporation Business Overview
Table 154. United BioSource Corporation Product
Table 155. United BioSource Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$)
Table 156. United BioSource Corporation Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pharmacovigilance (PV) Market Share by Type: 2020 VS 2026
Figure 2. Spontaneous Reporting Features
Figure 3. Intensified ADR Reporting Features
Figure 4. Targeted Spontaneous Reporting Features
Figure 5. Cohort Event Monitoring Features
Figure 6. EHR Mining Features
Figure 7. Global Pharmacovigilance (PV) Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Research Organizations Case Studies
Figure 10. Industrial Case Studies
Figure 11. Pharmacovigilance (PV) Report Years Considered
Figure 12. Global Pharmacovigilance (PV) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Pharmacovigilance (PV) Market Share by Regions: 2020 VS 2026
Figure 14. Global Pharmacovigilance (PV) Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Pharmacovigilance (PV) Market Share by Players in 2019
Figure 17. Global Top Pharmacovigilance (PV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance (PV) as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Pharmacovigilance (PV) Revenue in 2019
Figure 19. North America Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Accenture Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Accenture Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 28. Clinquest Group B.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Clinquest Group B.V. Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 30. Cognizant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Cognizant Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 32. Laboratory Corporation of America Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Laboratory Corporation of America Holdings Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 34. IBM Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. IBM Corporation Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 36. ArisGlobal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. ArisGlobal Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 38. ICON plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. ICON plc. Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 40. Capgemini Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Capgemini Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 42. ITClinical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. ITClinical Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 44. iMEDGlobal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. iMEDGlobal Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 46. Foresight Group International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Foresight Group International AG Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 48. TAKE Solutions Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. TAKE Solutions Ltd. Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 50. PAREXEL International Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. PAREXEL International Corporation Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 52. BioClinica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. BioClinica Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 54. Wipro Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Wipro Ltd. Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 56. United BioSource Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. United BioSource Corporation Revenue Growth Rate in Pharmacovigilance (PV) Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed